2024 Revenue
$2.7M
Customers
55.2K
Funding
$0
YOY
81.7%
Avg ACV
$50
Team
23
Founded
2016
How InSilicoTrials CEO Luca Emili grew InSilicoTrials to $2.7M revenue and 55.2K customers in 2024.
InSilicoTrials.com is a web-based platform, which provides a user-friendly computational modeling and simulation environment where many integrated easy-to-use in silico tools are readily available. The platform targets primarily users from the medical devices and pharmaceutical sectors. The in silico tools available for medical devices enable computational testing in different biomedical areas like radiology, orthopedics and cardiovascular during product design, development and validation processes. For the pharmaceutical sector, the platform provides access to in silico tools developed at all stages of the drug discovery and development processes and for many different therapeutic areas. The platform further ensures users management, content protection, simulation solvers, a validated environment, IT security, results reporting, pay-per-use licenses, the computational power of cloud machines and cloud storage.
Last updated
InSilicoTrials Revenue
In 2024, InSilicoTrials's revenue reached $2.7M. The company previously reported $1.5M in 2023. Since its launch in 2016, InSilicoTrials has shown consistent revenue growth.
| Year | Milestone | Quote |
|---|---|---|
| 2024 | InSilicoTrials Hit $2.7m revenue in October 2024 | |
| 2023 | InSilicoTrials Hit $1.5m revenue in October 2023 | |
| 2021 | InSilicoTrials Hit $1.3m revenue in April 2021 | |
| 2016 | Launched with $0 revenue |
InSilicoTrials Valuation, Funding Rounds
InSilicoTrials is a bootstrapped Other Analytics Software startup. Founded in 2016, InSilicoTrials has grown to $2.7M in revenue without raising any venture capital or outside funding.
As a self-funded Other Analytics Software SaaS company, InSilicoTrials has built its business with no outside investment.
| Year | Round | Amount | Valuation | % Sold | Quote |
|---|
InSilicoTrials Employees & Team Size
InSilicoTrials employs approximately 23 people as of 2026.
InSilicoTrials has 23 total employees in different roles and functions. They have 55.2K customers that rely on the company's solutions.
| Year | Milestone |
|---|---|
| 2024 | Reached 23 employees (October 2024) |
| 2023 | Reached 23 employees (October 2023) |
| 2022 | Reached 22 employees (October 2022) |
| 2021 | Reached 23 employees (December 2021) |
| 2021 | Reached 15 employees (April 2021) |
Founder / CEO
Luca Emili
I am a serial entrepreneur. With a background in the cybersecurity and IT-cloud sectors, a few years ago, decided to invest in healthcare by purchasing a small digital CRO (Contract Research Organization). I saw that pharma and Medtech were facing the same problems I had already solved in my career, so I founded InSilicoTrials Technologies and made it my mission to help the industry digitalize R&D and deliver better and safer cures, in a shorter timeframe, while saving money. To do that, I built close relationships with regulatory bodies, companies and associations like the Avicenna Alliance, where I lead the Good Simulation Practice for healthcare initiative. I believe that the healthcare industry is at a pivotal crossroad. We all know that R&D costs are rising year over year and became unsustainable for most of the players, putting innovation at risk. On top of that, the long certification/registration process is eroding the time on the market for which these costs can be recovered. In the meanwhile, patients desperately need better cures. Digitalization is seen as a possible solution, that already worked in other safety-critical industries, but the implementation is a huge challenge to face. I’ve built a team with a unique mix of competencies in computational science, drugs development, engineering, regulatory approval, and IT to put together a unique solution with a goal: De-risk and accelerate R&D and regulatory approval of medicines and medical devices through a game-changing approach to modeling and simulation. InSilicoTrials Technology makes it easy for scientists, researchers, and doctors to use the incredible knowledge developed in universities and research centers all over the world by collecting them on a web-based platform. Now there is a single stop point to use them, and our technology is making it so simple that they don’t need to be simulation experts to do it, but they can learn in a matter of minutes.
Q&A
| Question | Answer |
|---|---|
| What's your age? | - |
| Favorite online tool? | - |
| Favorite book? | - |
| Favorite CEO? | - |
| Advice for 20 year old self | - |
Customers
See how InSilicoTrials acquires and retains customers with data on acquisition costs and revenue performance. Log in to access the complete customer economics dashboard.
LockedFrequently Asked Questions about InSilicoTrials
What is InSilicoTrials's revenue?
InSilicoTrials generates $2.7M in revenue.
Who founded InSilicoTrials?
InSilicoTrials was founded by Luca Emili.
Who is the CEO of InSilicoTrials?
The CEO of InSilicoTrials is Luca Emili.
How much funding does InSilicoTrials have?
InSilicoTrials raised $0.
How many employees does InSilicoTrials have?
InSilicoTrials has 23 employees.
Where is InSilicoTrials headquarters?
InSilicoTrials is headquartered in Stafford, England, Italy.
People Also Viewed
NextME
NextME makes it simple for businesses to manage waitlists and serve more customers. Track visits and wait times, engage your customers in real-time with a custom virtual waiting room, and grow your business like never before. NextME leverages proprietary historical data to help businesses quote more accurate wait times during peak hours. We believe in superior customer service and that waiting in line can be done virtually, not physically. NextME's digital waitlist for businesses is available to download in the App Store today: http://apple.co/1IUTQWw We're hiring! See our current opening positions here: https://bit.ly/3llzOho Need an extra hand with a product demo? Give us a call at (877) 639-8631
BluAgent
BluAgent Technologies is a fully integrated SaaS platform that streamlines and simplify the entire safety and compliance process
Headway Essex
Headway Essex is a charity that supports people living with acquired brain injury, ensuring they can live a fulfilling life.
Digital Horizon
Digital Horizon is a VC firm focused on backing exceptional entrepreneurs building B2B software-based solutions and marketplaces. With a presence in London, Tel Aviv and Moscow, Digital Horizon aims to seek out early-stage technology companies with the ultimate goal to assist them in building and scaling their business.
Trefis
Provider of a business analysis technology. The company provides a data analytics technology for investors and decision-makers in business that allows users to share, use, and collaborate on analysis.
Liquid Logics
Liquid Logics, a True cloud-based SaaS Full Cycle Lending Software Solution for the residential Mortgage banking Industry. Based in the greater Kansas City area, Liquid Logics developed a full cycle Loan creation, Automated Underwriting and Mortgage Brief Case empowering borrower transparency and direct control of the loan process, changing their experience the way Travelocity did to the travel market. Liquid Logics unlike other legacy Loan Origination System who promise future roadmaps for online systems, provides today, online secure products that are focused on allowing consumers and lenders to effectively self-manage the flow of information and bi-directional direct communication between all interested parties of the transaction on all platform mobile, PC or tablets. The suite of products will provide real efficiency and profitability while gaining a competitive advantage. For more information please visit liquidlogics.com or contact us directly at 816-295-6240
Compare InSilicoTrials to the industry
InSilicoTrials operates across multiple industries. Browse revenue, funding, and growth data for InSilicoTrials in each sector below.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .
Data Disclaimer
All figures on this page are GetLatka estimates from public sources and proprietary models. They are not verified by the company.
Not financial advice. Read full disclaimer.
Claim this profile